(¬ provisional)
Ali, M.; Adler, M.; Libra, A.; Vokřál, I.; Karahoda, R.; Cífková, E.; Lísa, M.; Tomek, J.; Novotná, M.; Štaud, F.; Červený, L.*: Dynamic shifts in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestation and preterm birth. Scientific Reports, 2025, 15 (1), art.30275. JCR: IF24:3.9(Q1) AIS24:1.031(Q1) WOS:001553528800020 EID:2-s2.0-105013676265 PMID:40825832 DOI:10.1038/s41598-025-16183-2 OBD:673236»
Ali, MNH.; Adler, M.; Novotná, M.; Gala, V.; Abad, C.; Štaud, F.; Červený, L.*: Adenosine promotes trophoblast proliferation without inducing differentiation or apoptosis. Placenta, 2025, 172 (December), 150—158. JCR: IF24:2.5(Q2Q2Q2) AIS24:0.756(Q2Q2Q2) WOS:001620240000001 EID:2-s2.0-105021543535 PMID:41240505 DOI:10.1016/j.placenta.2025.11.005 OBD:673241»
Al-Otaibi, JS.*; Mary, YS.; Krátký, M.; Vinšová, J.; Gamberini, MC.: SERS Spectra and MD Simulations of a Bioactive Diiodobenzaldehyde Derivative: Experimental and Theoretical Investigations. ChemistrySelect, 2025, 10 (33), art.e02385. JCR: IF24:2.0(Q3) AIS24:0.268(Q3) WOS:001556724100001 EID:2-s2.0-105014503969 DOI:10.1002/slct.202502385 OBD:673497»
Applová, L.; Dudášová-Hatoková, P.; Kubeš, J.; Váňová, N.; Keresteš, V.; Reguli, A.; Jirkovská, A.; Roh, J.; Štěrba, M.; Štěrbová-Kovaříková, P.; Šimůnek, T.*: Daunorubicin and its hydroxy metabolite in cardiomyocytes: insights into cellular kinetics, toxicity, DNA damage, and dexrazoxane-induced cardioprotection. Archives of Toxicology, 2025, 99 (9), 3751—3768. JCR: IF24:6.9(Q1) AIS24:1.301(Q1) WOS:001503461700001 EID:2-s2.0-105007685032 PMID:40481868 DOI:10.1007/s00204-025-04095-z OBD:667323»
Asamoah, S.*; Pravda, M.*; Matonohová, J.; Bártová, T.; Šnejdrová, E.; Spiegel, S.; Chan, A.; Pernet, V.; Velebný, V.: Iron(II)-catalysed tyrosinase crosslinked hyaluronic acid hydrogel for the controlled release of human antibodies. Journal of Materials Chemistry B, 2025, 13 (23), 6804—6818. JCR: IF24:5.8(Q2) AIS24:0.929(Q2) WOS:001491494800001 EID:2-s2.0-105005748569 PMID:40395034 DOI:10.1039/D4TB02606C OBD:665585»
Asamoah, S.*; Pravda, M.; Šnejdrová, E.; Čepa, M.; Mrázek, J.; Gruber-Traub, C.; Velebný, V.: Photocrosslinked mucoadhesive hyaluronic acid hydrogel for transmucosal drug delivery. Journal of Biomedical Materials Research - Part B Applied Biomaterials, 2025, 113 (9), art.e35652. JCR: IF24:3.4(Q2Q3) AIS24:0.527(Q3Q3) WOS:001566621700001 EID:2-s2.0-105015564983 PMID:40916345 DOI:10.1002/jbm.b.35652 OBD:669415»
Attema, B.; Kummu, O.; Krutáková, M.; Pávek, P.; Hakkola, J.; Hooiveld, GJEJ.; Kersten, S.*: The fungicide propiconazole induces hepatic steatosis and activates PXR in a mouse model of diet-induced obesity. Archives of Toxicology, 2025, 99 (3), 1203—1221. JCR: IF24:6.9(Q1) AIS24:1.301(Q1) WOS:001382365900001 EID:2-s2.0-85212818237 PMID:39718591 DOI:10.1007/s00204-024-03942-9 OBD:673293»
Bajraktari-Sylejmani, G.; Kamaraj, R.; Theile, D.; Pávek, P.; Weiss, J.*: The "specific" P-glycoprotein inhibitor zosuquidar (LY335979) also weakly inhibits human organic cation transporters. Naunyn-Schmiedeberg's Archives of Pharmacology, 2025, 398 (6), 7147—7153. JCR: IF24:3.1(Q2) AIS24:0.508(Q3) WOS:001382372600001 EID:2-s2.0-85212836745 PMID:39718614 DOI:10.1007/s00210-024-03743-y OBD:673292»
Beranová, M.; Grossová, P.; Demuth, J.; Kostelanský, F.; Nováková, V.; Zimčík, P.; Miletín, M.*: Strain promoted click labeling of oligonucleotides on solid-phase support. Methods, 2025, 244 (December), 46—54. JCR: IF24:4.3(Q1Q2) AIS24:1.193(Q1Q2) WOS:001570944600001 EID:2-s2.0-105015514684 PMID:40921341 DOI:10.1016/j.ymeth.2025.09.001 OBD:673143»
Boltnarová, B.; Ďurinová, A.; Jandová, L.; Mičuda, S.; Kučera, O.; Pávková, I.; Macháček, M.; Němečková, I.; Vojta, M.; Dušek, J.; Krutáková, M.; Nachtigal, P.; Pávek, P.; Holas, O.*: Dexamethasone Acetate-Loaded PLGA Nanospheres Targeting Liver Macrophages. Macromolecular Bioscience, 2025, 25 (2), art.2400411. JCR: IF24:4.1(Q2Q3Q2) AIS24:0.695(Q3Q2Q1) WOS:001366394400001 EID:2-s2.0-85210762746 PMID:39611304 DOI:10.1002/mabi.202400411 OBD:655770»
Brezesinski, G.; Opálka, L.; Shen, Ch.; Groetzsch, C.; Schneck, E.; Eichner, A.*: Structure-Function Relationship of the Most Abundant Ceramide Subspecies Studied on Monolayer Models Using GIXD and Langmuir Isotherms. Langmuir, 2025, 41 (22), 14255—14264. JCR: IF24:3.9(Q2Q2Q2) AIS24:0.592(Q2Q2Q2) WOS:001497475300001 EID:2-s2.0-105006737550 PMID:40424481 DOI:10.1021/acs.langmuir.5c01340 OBD:672707»
Brkić, J.*; Reissigová, J.; Okuyan, B.; Ortner Hadžiabdić, M.; Marinković, V.; Somers, A.; Onder, G.; Šesto, S.; Altiparmak, Ö.; Kummer, I.; Držaić, M.; Fialová, D.: Assessing potentially inappropriate medication use among older adults in Central and Eastern Europe. Annals of Medicine, 2025, 57 (1), art.2579794. JCR: IF24:4.3(Q1) AIS24:1.078(Q1) WOS:001607385700001 EID:2-s2.0-105020774112 PMID:41186387 DOI:10.1080/07853890.2025.2579794 OBD:673356»
Carazo, A.; Paclíková, M.; Fadraersada, J.; Alva Gallegos, R.; Skořepa, P.; Gunaseelan, C.; Matoušová, K.; Mrštná, K.; Kujovská Krčmová, L.; Šmahelová, A.; Blaha, V.; Mladěnka, P.*: Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants. PLoS One, 2025, 20 (6), art.e0326580. JCR: IF24:2.6(Q2) AIS24:0.831(Q2) WOS:001513830700030 EID:2-s2.0-105008825968 PMID:40549719 DOI:10.1371/journal.pone.0326580 OBD:667435»
Čečrle, M.; Mžik, M.; Dlabková, A.; Múčková, Ľ.; Hrabinová, M.; Fikejzlová, L.; Opravil, J.; Váňová, N.; Hejna, P.; Pohlová Kučerová, Š.; Astapenko, D.; Jakl, M.; Chládek, J.; Žďárová Karasová, J.; Pejchal, J.*: A case report of fatal chlormequat poisoning: Identification of potential additional mechanism of toxicity. Science Progress, 2025, 108 (4), art.00368504251386979. JCR: IF24:2.9(Q2) AIS24:0.527(Q2) WOS:001607499200001 EID:2-s2.0-105020772052 PMID:41186503 DOI:10.1177/00368504251386979 OBD:672715»
Demir, D.; Antos, J.; Švec, F.; Sklenářová, H.*: Recent Developments in Deep Eutectic Solvents Applications in Liquid Chromatography: 2019-2025. Journal of Separation Science, 2025, 48 (5), art.e70160. JCR: IF24:2.8(Q2) AIS24:0.350(Q3) WOS:001482495900001 EID:2-s2.0-105004416527 PMID:40329693 DOI:10.1002/jssc.70160 OBD:668244»
Demuth, J.; Bednárik, Š.; Machan, R.; Mocák, I.; Malinský, T.; Abo El Dahabová, M.; Holčák, J.; Miletín, M.; Labuta, J.; Nováková, V.; Zimčík, P.*: J-dimers of phthalocyanine analogues: structural characterization and their use for determination of association constants between ligands and the central cation. Inorganic Chemistry Frontiers, 2025, 12 (4), 1590—1608. JCR: IF24:6.4(Q1) AIS24:0.919(Q1) WOS:001395371600001 EID:2-s2.0-85215859599 DOI:10.1039/d4qi02834a OBD:673305»
Dias, P.; Siatka, T.; Vopršalová, M.; Moravcová, M.; Pourová, J.; Přívratská, N.; Kujovská Krčmová, L.; Javorská, L.; Mladěnka, P.*: Biological properties of vitamins of the B-complex, part 2 - vitamins B6 and B7 (biotin, vitamin H). Nutrition Research Reviews, 2025, 38 (2), 791—824. JCR: IF24:4.5(Q1) AIS24:1.757(Q1) WOS:001546219400001 EID:2-s2.0-105007325740 PMID:40443009 DOI:10.1017/S0954422425100097 OBD:668139»
Diepoltová, A.; Nawrot, DE.; Janďourek, O.; Juhás, M.; Bárta, P.; Vávrová, P.; Pallabothula, VSK.; Dudášová-Hatoková, P.; Vejsová, M.; Voxová, B.; Österreicher, J.; Štěrbová-Kovaříková, P.; Nachtigal, P.; Zitko, J.; Konečná, K.*: A new bactericidal chlorinated derivative containing 2-aminooxazole potentiates antibacterial action of colistin against multidrug-resistant acinetobacter baumannii. Medical Microbiology and Immunology, 2025, 214 (1), art.44. JCR: IF24:3.0(Q3Q3) AIS24:0.846(Q3Q2) WOS:001576020100002 EID:2-s2.0-105016608044 PMID:40971029 DOI:10.1007/s00430-025-00854-y OBD:673233»
Dušek, J.; Mejdrová, I.; Dohnalová, K.; Smutný, T.; Chalupský, K.; Krutáková, M.; Škoda, J.; Rashidian, A.; Pávková, I.; Škach, K.; Hricová, J.; Chocholoušková, M.; Smutná, L.; Kamaraj, R.; Hroch, M.; Leníček, M.; Mičuda, S.; Pijnenburg, D.; van Beuningen, R.; Holčapek, M.; Vítek, L.; Ingelman-Sundberg, M.; Burk, O.; Kronenberger, T.; Nencka, R.*; Pávek, P.*: The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model. Nature Communications, 2025, 16 (1), art.1418. JCR: IF24:15.7(Q1) AIS24:5.622(Q1) WOS:001416001300010 EID:2-s2.0-85218266836 PMID:39915454 DOI:10.1038/s41467-025-56642-y OBD:663779»
Eissazadeh, S.; Fikrová, P.; Urbánková Rathouská, J.; Němečková, I.; Tripská, K.; Vašinová, M.; Havelek, R.; Mohammadi, SN.; Igreja e Sá, IC.; Theuer, Ch.; König, M.; Mičuda, S.; Nachtigal, P.*: Anti-Endoglin monoclonal antibody prevents the progression of liver sinusoidal endothelial inflammation and fibrosis in MASH. Life Sciences, 2025, 364 (March), art.123428. JCR: IF24:5.1(Q1Q1) AIS24:0.998(Q2Q1) WOS:001436435500001 EID:2-s2.0-85216279589 PMID:39889923 DOI:10.1016/j.lfs.2025.123428 OBD:667449»
Eissazadeh, S.; Urbánková Rathouská, J.; Němečková, I.; Fikrová, P.; Tripská, K.; Vašinová, M.; Koláčková, M.; Nachtigal, P.*: Cost-effective method for semi-quantitative analysis of soluble endoglin in biological samples after anti-endoglin monoclonal antibody treatment. Scientific Reports, 2025, 15 (1), art.38066. JCR: IF24:3.9(Q1) AIS24:1.031(Q1) WOS:001606742300002 EID:2-s2.0-105020405920 PMID:41168366 DOI:10.1038/s41598-025-21972-w OBD:673014»
Fadraersada, J.; Alva Gallegos, R.; Skořepa, P.; Musil, F.; Mrštná, K.; Javorská, L.; Matoušová, K.; Kujovská Krčmová, L.; Paclíková, M.; Carazo, A.*; Bláha, M.; Blaha, V.; Mladěnka, P.: Coagulation in familial hypercholesterolemic patients: effect of current hypolipidemic treatment and anticoagulants. Naunyn-Schmiedeberg's Archives of Pharmacology, 2025, 398 (6), 7343—7352. JCR: IF24:3.1(Q2) AIS24:0.508(Q3) WOS:001388914600001 EID:2-s2.0-85213950846 PMID:39751820 DOI:10.1007/s00210-024-03740-1 OBD:667322»
Finger, V.*; Vrbický, M.; Múčková, Ľ.; Prchal, L.; Novák, M.; Marek, J.; Soukup, O.; Hympánová, M.; Šorf, A.; Benková, M.; Bartáček, J.; Drabina, P.; Kufa, M.; Kovář, O.; Fikejzlová, L.; Hrubý, M.; Ozhelevska, O.; Jagob, J.; Žďárová-Karasová, J.; Odvárková, J.; Kadeřávková, I.; Rozsypal, T.; Greber, KE.; Ciura, K.; Janoušek, J.; Krátký, M.; Igreja Sá, IC.; Boštík, P.; Sleha, R.; Roh, J.; Korábečný, J.*: Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidines. Biomedicine & Pharmacotherapy, 2025, 191 (October), art.118537. JCR: IF24:7.5(Q1Q1) AIS24:1.328(Q1Q1) WOS:[On Hold] EID:2-s2.0-105015484225 PMID:40945271 DOI:10.1016/j.biopha.2025.118537 OBD:672815»
Frolov, V.*; Sovány, T.; Loskot, J.; Csapó, E.; Varga, N.; Hassan, AAA.; Janďourek, O.; Konečná, K.; Bezrouk, A.; Šnejdrová, E.: Ion-paired antibiotics in PLGA nanoparticles: improving encapsulation efficiency and musculoskeletal infection treatment. RSC Advances, 2025, 15 (54), 46024—46036. JCR: IF24:4.6(Q2) AIS24:0.623(Q2) WOS:001621222100001 EID:2-s2.0-105022755636 PMID:41293294 DOI:10.1039/D5RA04263A OBD:672580»
Gaffour, A.; Bakker, M.; Bera, K.; Pavlíková Přecechtělová, J.*: Reduced binding of Tau(210-240) to BIN1: Phosphate charges prefer n-Src/distal loops over RT-Src loops. Biophysical Journal, 2025, 124 (21), 3800—3810. JCR: IF24:3.1(Q2) AIS24:1.095(Q1) WOS:001616097400027 EID:2-s2.0-105020027602 PMID:41035200 DOI:10.1016/j.bpj.2025.09.037 OBD:673493»
Galvez B. Pedreira, J.; Woelffing, P.; Schwarz, M.; Ebner, S.; Rudalska, R.; Masberg, B.; Esposito, A.; Rashidian, A.; Schevchenko, E.; Smutná, L.; Pávek, P.; Küblbeck, J.; Kronenberger, T.; Zender, L.; Lämmerhofer, M.; Dauch, D.*; Laufer, SA.*: Uncovering alpha-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies. Journal of Medicinal Chemistry, 2025, 68 (7), 7180—7196. JCR: IF24:6.8(Q1) AIS24:1.589(Q1) WOS:001450969100001 EID:2-s2.0-105000633999 PMID:40127224 DOI:10.1021/acs.jmedchem.4c02712 OBD:673291»
Górecki, L.*; Řezníčková, E.; Kryštof, V.; Řezáčová, M.; Čečková, M.; Korábečný, J.*: Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review. Expert Opinion on Therapeutic Patents, 2025, 35 (2), 137—164. JCR: IF24:4.6(Q2Q1) AIS24:1.039(Q1Q1) WOS:001391169100001 EID:2-s2.0-85214473851 PMID:39718422 DOI:10.1080/13543776.2024.2446224 OBD:660009»
Harčárová, P.; Lomozová, Z.; Kallivretaki, M.; Karlíčková, J.; Kučera, R.; Mladěnka, P.*: Different behavior of food-related benzoic acids toward iron and copper. Food Chemistry, 2025, 462 (January), art.141014. JCR: IF24:9.8(Q1Q1Q1) AIS24:1.150(Q1Q1Q1) WOS:001316494200001 EID:2-s2.0-85202877831 PMID:39226645 DOI:10.1016/j.foodchem.2024.141014 OBD:654797»
Hartinger, JM.*; Tašková, I.; Gregorová, J.; Slanař, O.; Fialová, D.: ESCP best practice: development of the national methodology for the provision of clinical-pharmaceutical care and its implementation in the healthcare system of the Czech Republic. International Journal of Clinical Pharmacy, 2025, 47 (6), 1955—1966. JCR: IF24:3.2(Q2) AIS24:0.623(Q2) WOS:001584108500001 EID:2-s2.0-105017489252 PMID:41026336 DOI:10.1007/s11096-025-02009-8 OBD:671715»
Hiltunen, A.; Haavisto, I.; Nuutinen, M.; Lahelma, M.; Salminen, A.; de Almeida Mello, J.*; Liperoti, R.; Howard, EP.; Fialová, D.; Szczerbińska, K.; Alon, M.; Barańska, I.; Exmann, C.; Declercq, A.; Boorsma, W.; Onder, G.; van Hout, HPJ.; Leskelä, R.: Protocol of the pilot study to test and evaluate the iCARE tool: a machine learning-based e-platform tool to make health prognoses and support decision-making for the care of older persons with complex chronic conditions. BMJ Open, 2025, 15 (4), art.e101234. JCR: IF24:2.3(Q2) AIS24:0.886(Q1) WOS:001541670700001 EID:2-s2.0-105003794787 PMID:40254305 DOI:10.1136/bmjopen-2025-101234 OBD:673362»
Holec, P.; Háková, M.; Kolichová, I.; Vinter, J.; Kalous, T.; Hujerová, M.; Šatínský, D.*; Erben, J.*: Graphene-high rich polycaprolactone nanofibers prepared via alternating current electrospinning as advanced sustainable sorbents for environmental analysis. Environmental Technology and Innovation, 2025, 40 (November), art.104591. JCR: IF24:7.1(Q1Q1Q1) AIS24:0.992(Q1Q2Q2) WOS:001616559300002 EID:2-s2.0-105021081506 DOI:10.1016/j.eti.2025.104591 OBD:673461»
Horáček, O.; Lochman, L.; Linková, K.; Tüzün, EZ.; Grüner, B.; Kučera, R.*: Cyclodextrin mediated non-aqueous electrophoresis for chiral separations of anionic boron clusters. Talanta, 2025, 293 (October), art.128117. JCR: IF24:6.1(Q1) AIS24:0.769(Q1) WOS:001473477200001 EID:2-s2.0-105002369633 PMID:40239590 DOI:10.1016/j.talanta.2025.128117 OBD:666624»
Horáčková, H.; Musilová-Kacerovská, I.; Abad, C.; Karahoda, R.; Váchalová, V.; Portillo, R.; Viňas-Noguera, M.; Yadunandam, K.; Heblík, D.; Cífková, E.; Lísa, M.; Štěrba, M.; Stráník, J.; Bonnin, A.; Štaud, F.*: Prenatal paroxetine dysregulates monoamine homeostasis and affects placental hemodynamics in the rat fetoplacental unit. Biomedicine & Pharmacotherapy, 2025, 192 (November), art.118680. JCR: IF24:7.5(Q1Q1) AIS24:1.328(Q1Q1) WOS:[On Hold] EID:2-s2.0-105020878919 PMID:41138656 DOI:10.1016/j.biopha.2025.118680 OBD:672757»
Horstkotte, B.; Ren, X.; Maya, F.: 3D-printed scaffolds for sample handling and preparation. In: 3D Printing in Analytical Chemistry. Sample Preparation, Separation, and Sensing. Amsterdam: Elsevier, 2025, 103—139. ISBN 978-0-443-15675-5. EID:2-s2.0-85218370288 DOI:10.1016/B978-0-443-15675-5.00005-7 OBD:668574»
Houngbedji, P.*; Nawrot, DE.; Janďourek, O.; Konečná, K.; Novák, M.; Paterová, P.; Bárta, P.; Hrast Rambaher, M.; Novotná, E.; Castellano, C.; Mori, M.; Meneghetti, F.; Záhorszká, M.; Korduláková, J.; Zitko, J.*: Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)-N'-Benzylidenepyrazine-2-Carbohydrazides and their Derivatives. ChemMedChem, 2025, 20 (18), art.202500085. JCR: IF24:3.4(Q2Q2) AIS24:0.627(Q2Q2) WOS:001560221300001 EID:2-s2.0-105014462939 PMID:40879650 DOI:10.1002/cmdc.202500085 OBD:673207»
Hrast Rambaher, M.; Gradišek, N.; Frlan, R.; Sosič, I.; Bolje, A.; Kljun, J.; Juhás, M.; Gobec, S.; Pajk, S.*: Development and evaluation of novel InhA inhibitors inspired by thiadiazole and tetrahydropyran series of inhibitors. Acta Pharmaceutica, 2025, 75 (2), 185—218. JCR: IF24:1.4(Q4) AIS24:0.337(Q4) WOS:001522094000008 EID:2-s2.0-105010547489 PMID:40608557 DOI:10.2478/acph-2025-0016 OBD:672590»
Hrubša, M.; Soloviova, A.; Gunaseelan, C.; Harčárová, P.; Lomozová, Z.; Jirkovský, E.; Carazo, A.; Sollner Dolenc, M.; Peterlin Mašič, L.; Mladěnka, P.*: A novel bisphenol A alternative, DD-70, may negatively affect haemostasis through cyclooxygenase 1 inhibition. Environment International, 2025, 203 (September), art.109738. JCR: IF24:9.7(Q1) AIS24:2.654(Q1) WOS:001563970900005 EID:2-s2.0-105014294878 PMID:40882420 DOI:10.1016/j.envint.2025.109738 OBD:672639»
Htet, TTM.; Gemuh, CV.; Yildirim, S.; Sklenářová, H.; Solich, P.; Horstkotte, B.*: Lab-in-syringe automated dispersive solid-phase microextraction of alkylphenols coupled online to liquid chromatography using iron(III) thenoyltrifluoroacetonate as dissolvable sorbent. Analytica Chimica Acta, 2025, 1345 (April), art.343764. JCR: IF24:6.0(Q1) AIS24:0.837(Q1) WOS:001424888500001 EID:2-s2.0-85216879687 PMID:40015793 DOI:10.1016/j.aca.2025.343764 OBD:668563»
Chełminiak-Dudkiewicz, D.*; Długaszewska, J.; Wujak, M.; Smolarkiewicz-Wyczachowski, A.; Mylkie, K.; Macháček, M.; Ziegler-Borowska, M.: Chitosan- and levan-based wound dressings crosslinked with dialdehyde levan: Structural and biological stability under climatic aging. International Journal of Biological Macromolecules, 2025, 321 (September), art.146207. JCR: IF24:8.5(Q1Q1Q1) AIS24:1.011(Q2Q1Q1) WOS:001540522800006 EID:2-s2.0-105011167583 PMID:40706927 DOI:10.1016/j.ijbiomac.2025.146207 OBD:673097»
Jadeja, S.; Naplekov, DK.; Starovoit, MR.; Plachká, K.; Ritchie, H.; Lawhorn, J.; Sklenářová, H.; Lenčo, J.*: Microflow LC-MS Bottom-Up Proteomics Using 1.5 mm Internal Diameter Columns. ACS Omega, 2025, 10 (4), 4094—4101. JCR: IF24:4.3(Q2) AIS24:0.674(Q2) WOS:001406188700001 EID:2-s2.0-85216106426 PMID:39926544 DOI:10.1021/acsomega.4c10591 OBD:673354»
Juhásová, Z.; Karapinar-Çarkit, F.; Weir, DL.*: The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study. British Journal of Clinical Pharmacology, 2025, 91 (10), 2910—2918. JCR: IF24:3.0(Q2) AIS24:1.073(Q1) WOS:001500013100001 EID:2-s2.0-105007232461 PMID:40452631 DOI:10.1002/bcp.70116 OBD:670656»
Kamaraj, R.; Mehran, MJ.; Tiwari, H.; Shukla, MK.; Cetiz, MV.; Basharat, Z.; Barzigar, R.; Jalili, S.; Pávek, P.; Kumavath, R.; Paul, MK.; Haider, KH.; Paul, S.*: Role of stem cells in diabetes, liver disease, and cancer treatment. In: Handbook of Regenerative Medicine. Stem Cell Based Approach. Boca Raton: CRC Press, 2025, 404—420. ISBN 978-1-03-273519-1. EID:2-s2.0-105012043531 DOI:10.1201/9781003464594-26 OBD:673298»
Kamaraj, R.; Mejdrová, I.; Krutáková, M.; Smutný, T.; Škach, K.; Dohnalová, K.; Smutná, L.; Nellore, DSS.; Dušek, J.; Chalupský, K.; Hricová, J.; Kronenberger, T.; Stahl, A.; Templin, M.; Braeuning, A.; Nencka, R.*; Pávek, P.*: Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene Regulation. Journal of Medicinal Chemistry, 2025, 68 (14), 14271—14299. JCR: IF24:6.8(Q1) AIS24:1.589(Q1) WOS:001527357600001 EID:2-s2.0-105010458732 PMID:40650588 DOI:10.1021/acs.jmedchem.4c03134 OBD:673289»
Karahoda, R.*; Du Toit, T.; Fuenzalida, B.; Kallol, S.; Groessl, M.; Anderle, P.; Ontsouka, E.; Štaud, F.; Flueck, ChE.; Albrecht, C.*: Landscape of Steroid Dynamics in Pregnancy: Insights From the Maternal-Placental-Fetal Unit and Placental Models. Molecular and Cellular Proteomics, 2025, 24 (6), art.100976. JCR: IF24:5.5(Q1) AIS24:2.203(Q1) WOS:001498701000001 EID:2-s2.0-105010571890 PMID:40280488 DOI:10.1016/j.mcpro.2025.100976 OBD:672583»
Kerda, M.*; Nawrot, D.; Šlechta, P.; Domanský, M.; Askari, A.; Kamangar, H.; Janďourek, O.; Konečná, K.; Paterová, P.; Hlbočanová, I.; Macháček, M.; Mori, M.; Meneghetti, F.; Doležal, M.; Zitko, J.; Bouz, G.*: Novel Quinazolinones Active against Multidrug-Resistant Mycobacterium Tuberculosis: Synthesis, Antimicrobial Evaluation, and in Silico Exploration of Penicillin-Binding Protein 1A as a Potential Target. ChemMedChem, 2025, 20 (13), art.e202500147. JCR: IF24:3.4(Q2Q2) AIS24:0.627(Q2Q2) WOS:001507990500001 EID:2-s2.0-105006847508 PMID:40237183 DOI:10.1002/cmdc.202500147 OBD:667451»
Kirmizibekmez, H.*; Aru, B.; Křoustková, J.*; Erdogan, M.; Torrence, I.; Ando, K.; Tantillo, DJ.; Malaník, M.; Kosturko, Š.; Kuneš, J.; Cahlíková, L.: Cytotoxic Stilbenoids, Hetero- and Homodimers of Homoisoflavonoids from Prospero autumnale. Journal of Natural Products, 2025, 88 (2), 458—468. JCR: IF24:3.6(Q2Q2Q1) AIS24:0.733(Q2Q2Q2) WOS:001406187900001 EID:2-s2.0-85216318544 PMID:39855634 DOI:10.1021/acs.jnatprod.4c01263 OBD:672605»
Konzack, A.; Karpale, M.; Smutný, T.; Hassanen, M.; Lassila, P.; Ahonen, MH.; Elkhwanky, M.; Kummu, O.; Pávek, P.; Hakkola, J.*: LIM and SH3 protein 2 (Lasp2) is a novel pregnane X receptor target gene in mouse liver. Molecular Pharmacology, 2025, 107 (3), art.100019. JCR: IF24:3.0(Q2) AIS24:0.876(Q2) WOS:001436933000001 EID:2-s2.0-85218895601 PMID:40023092 DOI:10.1016/j.molpha.2025.100019 OBD:672674»
Kooijmans, ECM.*; Hoogendijk, EO.; Drapała, N.; Antonenko, O.; Burchell, GL.; Barańska, I.; Pokladníková, J.; Szczerbińska, K.; Fialová, D.; van Hout, HPJ.; Joling, KJ.: Defining and Categorizing Nonpharmacologic Interventions in the Older Population: A Systematic Review. Journal of the American Medical Directors Association, 2025, 26 (1), art.105306. JCR: IF24:3.8(Q2) AIS24:1.587(Q1) WOS:001354476900001 EID:2-s2.0-85208095037 PMID:39424279 DOI:10.1016/j.jamda.2024.105306 OBD:673187»
Kosolapov, D.; Bařinka, F.; Gazárková, T.; Moreno-González, D.; Nováková, L.; Jáč, P.*: Development of CE-MS/MS method for unravelling nonsteroidal anti-inflammatory drugs as potential adulterants of Boswellia serrata extract. Talanta, 2025, 294 (November), art.128112. JCR: IF24:6.1(Q1) AIS24:0.769(Q1) WOS:001483799900001 EID:2-s2.0-105003723987 PMID:40300475 DOI:10.1016/j.talanta.2025.128112 OBD:672908»
Kosolapov, D.; Jáč, P.*; Riasová, P.; Poušková, J.; Polášek, M.; Nováková, L.: Advances and Challenges in the Analysis of Boswellic Acids by Separation Methods. Critical Reviews in Analytical Chemistry, 2025, 55 (4), 748—774. JCR: IF24:5.2(Q1) AIS24:0.887(Q1) WOS:001183130600001 EID:2-s2.0-85187449736 PMID:38462842 DOI:10.1080/10408347.2024.2312502 OBD:655599»
Kovář, O.; Kufa, M.; Finger, V.; Soukup, O.; Krátký, M.; Torruellas, C.; Roh, J.*; Korábečný, J.*: Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies. Journal of Medicinal Chemistry, 2025, 68 (20), 20903—20929. JCR: IF24:6.8(Q1) AIS24:1.589(Q1) WOS:001588852000001 EID:2-s2.0-105019559240 PMID:41055946 DOI:10.1021/acs.jmedchem.5c01100 OBD:671881»
Krátký, J.; Zajíčková, M.; Taki, AC.; Michel, O.; Matoušková, P.; Vokřál, I.; Štěrbová, K.; Vosála, O.; Lungerich, B.; Kurz, T.; Gasser, RB.; Harant, K.; Skálová, L.*: New derivatives of benzhydroxamic acid with nematocidal activity against Haemonchus contortus and Caenorhabditis elegans. International Journal for Parasitology: Drugs and Drug Resistance, 2025, 28 (August), art.100599. JCR: IF24:3.4(Q1Q2) AIS24:0.894(Q1Q2) WOS:001505154500001 EID:2-s2.0-105005737725 PMID:40413827 DOI:10.1016/j.ijpddr.2025.100599 OBD:666594»
Kubeš, J.; Karabanovich, G.; Cong, ATQ.; Melnikova, I.; Lenčová, O.; Kollárová, P.; Bavlovič Piskáčková, H.; Keresteš, V.; Applová, L.; Arrouye, LCM.; Alvey, JR.; Paluncic, J.; Witter, TL.; Jirkovská, A.; Kuneš, J.; Štěrbová-Kovaříková, P.; Austin, CA.*; Štěrba, M.*; Šimůnek, T.*; Roh, J.*; Schellenberg, MJ.*: Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection. Nature Communications, 2025, 16 (1), art.4928. JCR: IF24:15.7(Q1) AIS24:5.622(Q1) WOS:001497431600001 EID:2-s2.0-105006812066 PMID:40425539 DOI:10.1038/s41467-025-60167-9 OBD:667595»
Kučerová, M.*: Kovalentní léčiva. Česká a slovenská farmacie, 2025, 74 (1), E11—E16. EID:TBA DOI:10.36290/csf.2025.001 OBD:672819»
Kučerová-Chlupáčová, M.*: Systematic Review on 1,2,3-Oxadiazoles, 1,2,4-Oxadiazoles, and 1,2,5-Oxadiazoles in the Antimycobacterial Drug Discovery. ChemMedChem, 2025, 20 (9), art.e202400971. JCR: IF24:3.4(Q2Q2) AIS24:0.627(Q2Q2) WOS:001412433800001 EID:2-s2.0-85216876018 PMID:39846226 DOI:10.1002/cmdc.202400971 OBD:672582»
Kufa, M.; Finger, V.; Kovář, O.; Soukup, O.; Torruellas, C.; Roh, J.; Korábečný, J.*: Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon. Acta Pharmaceutica Sinica B, 2025, 15 (3), 1311—1332. JCR: IF24:14.6(Q1) AIS24:2.818(Q1) WOS:001464726500001 EID:2-s2.0-105001804343 PMID:40370552 DOI:10.1016/j.apsb.2025.01.023 OBD:659314»
Kujovská Krčmová, L.*; Matoušová, K.; Javorská, L.; Mrštná, K.; Přívratská, N.; Suwanvecho, Ch.; Turoňová, D.; Farrag, M.; Kacerovský, M.; Melichar, B.: Urinary kynurenine, tryptophan, and neopterin concentrations during physiological pregnancy. Scientific Reports, 2025, 15 (1), art.19674. JCR: IF24:3.9(Q1) AIS24:1.031(Q1) WOS:001503073900013 EID:2-s2.0-105007248433 PMID:40467872 DOI:10.1038/s41598-025-04642-9 OBD:666464»
Laštůvková, H.; Dohnálková, E.; Manna, D.; Cermanová, J.; Mokrý, J.; Pejchal, J.; Hiršová, P.; Nachtigal, P.; Pávková, I.; Bajnoková, M.; Smutná, L.; Štefela, A.; Kamaraj, R.; Jandová, L.; Uher, M.; Pávek, P.; Mičuda, S.*; Hroch, M.: Dimethyl fumarate attenuates bile acid retention and liver fibrosis in a mouse model of cholestasis. American Journal of Physiology - Gastrointestinal and Liver Physiology, 2025, 328 (5), G558—G577. JCR: IF24:3.3(Q2Q2) AIS24:1.197(Q1Q1) WOS:001484055000001 EID:2-s2.0-105004185039 PMID:40210415 DOI:10.1152/ajpgi.00262.2024 OBD:666726»
Lochman, L.; Kahiya, ET.; Saade, B.; Smutný, T.; Duintjer Tebbens, J.; Pávek, P.; Bernhauerová, V.*: Quantifying expression and metabolic activity of genes regulated by pregnane X receptor in primary human hepatocyte spheroids. PLoS Computational Biology, 2025, 21 (4), art.e1012886. JCR: IF24:3.6(Q2Q1) AIS24:1.744(Q1Q1) WOS:001489617000005 EID:2-s2.0-105002780485 PMID:40233301 DOI:10.1371/journal.pcbi.1012886 OBD:673084»
Malá-Ládová, K.*; Rožníčková, E.; Rozsívalová, P.: Zdroje dat a odborných informací o farmakoterapii v těhotenství. Česká a slovenská farmacie, 2025, 74 (2), 108—113. EID:TBA DOI:10.36290/csf.2025.015 OBD:672523»
Malá-Ládová, K.*; Rožníčková, E.; Rozsívalová, P.: Zdroje dat a odborných informací o farmakoterapii v kojení. Česká a slovenská farmacie, 2025, 74 (3), 172—178. EID:TBA DOI:10.36290/csf.2025.030 OBD:672524»
Mašková, E.; Slivárichová, S.; Malý, J.; Malá-Ládová, K.*: Electronic Monitoring of Medication Adherence to Direct Oral Anticoagulants: A Systematic Review. Patient Preference and Adherence, 2025, 19 (April), 921—939. JCR: IF24:2.0(Q2) AIS24:0.632(Q2) WOS:001462629300001 EID:2-s2.0-105003265595 PMID:40223821 DOI:10.2147/PPA.S505485 OBD:672640»
Melek, J.; Staňková, P.; Peterová, E.; Maseko, TE.; Špalková, V.; Matar, R.; Ibrahim, A.; Elkalaf, M.; Podhola, M.; Štefela, A.; Červinková, Z.; Pávek, P.; Kučera, O.*: Obeticholic acid does not restore Western diet-induced alterations in hepatic mitochondrial respiration. Biomedicine & Pharmacotherapy, 2025, 192 (November), art.118542. JCR: IF24:7.5(Q1Q1) AIS24:1.328(Q1Q1) WOS:[On Hold] EID:2-s2.0-105016255577 PMID:40967077 DOI:10.1016/j.biopha.2025.118542 OBD:671928»
Mladěnka, P.*; Fadraersada, J.; Dias, P.; Tvrdý, V.; Pourová, J.; Jirkovský, E.; Carazo, A.; Gunaseelan, C.; Harčárová, P.; Lomozová, Z.; Sollner Dolenc, M.; Trontelj, J.; Peterlin Mašič, L.: The first subacute study with oral administration of bisphenol AP in male rats: Cardiovascular data and metabolite detection. Ecotoxicology and Environmental Safety, 2025, 304 (October), art.119143. JCR: IF24:6.1(Q1Q1) AIS24:1.083(Q2Q1) WOS:001589677300004 EID:2-s2.0-105017706998 PMID:41043232 DOI:10.1016/j.ecoenv.2025.119143 OBD:672638»
Moravcová, M.; Siatka, T.; Kujovská Krčmová, L.; Matoušová, K.; Mladěnka, P.*: Biological properties of vitamin B12. Nutrition Research Reviews, 2025, 38 (1), 338—370. JCR: IF24:4.5(Q1) AIS24:1.757(Q1) WOS:001331174800001 EID:2-s2.0-85206290848 PMID:39376196 DOI:10.1017/S0954422424000210 OBD:661014»
Moravcová, P.; Schröterová, L.; Stříbrná, V.; Švec, F.; Šatínský, D.*: A UHPLC-DAD method for quantification of curcuminoids and piperine in food supplements based on Curcuma longa extract and evaluation of their biological activity on the Hep-2 cell lines. Journal of Food Composition and Analysis, 2025, 145 (September), art.107833. JCR: IF24:4.6(Q2Q2) AIS24:0.585(Q2Q2) WOS:001501637800003 EID:2-s2.0-105006648121 DOI:10.1016/j.jfca.2025.107833 OBD:667413»
Moravcová, P.; Schröterová, L.; Zíka, J.; Hošťálková, A.; Švec, F.; Šatínský, D.*: A UHPLC-DAD method for quantification of berberine and protoberberine alkaloids in herbal food supplements based on Berberis aristata extract and evaluation of their biological activity. Journal of Food Composition and Analysis, 2025, 139 (March), art.107150. JCR: IF24:4.6(Q2Q2) AIS24:0.585(Q2Q2) WOS:001401666700001 EID:2-s2.0-85213287787 DOI:10.1016/j.jfca.2024.107150 OBD:664640»
Moravcová, P.; Špánik, I.; Škop, J.; Horna, A.; Švec, F.; de Araújo Gomes, A.; Šatínský, D.*: The profiling of phenolic compounds in archive Tokaj wines using liquid chromatography and antioxidant activity analysis. Food Chemistry: X, 2025, 30 (August), art.102897. JCR: IF24:8.2(Q1Q1) AIS24:1.047(Q1Q1) WOS:001584478800007 EID:2-s2.0-105012821844 PMID:40831962 DOI:10.1016/j.fochx.2025.102897 OBD:673458»
Morris, JN.; Howard, EP.*; Schachter, E.; Burney, SN.; Laytham, A.; Fialová, D.; Pešić, V.: Predicting risk of hospitalization among adult home care clients: An international perspective. Geriatric Nursing, 2025, 64 (July), art.103418. JCR: IF24:2.4(Q3Q2Q1) AIS24:0.663(Q3Q3Q2) WOS:001528164700001 EID:2-s2.0-105009593567 PMID:40614290 DOI:10.1016/j.gerinurse.2025.103418 OBD:673386»
Mubarak, TH.; Maulita, S.; Adianingsih, OR.; Duintjer Tebbens, J.; Shimosato, T.; Yurina, V.*: Optimization of growth conditions and the inducer concentration for increasing spike protein expression in recombinant Lactococcus lactis and its kinetic modeling. Bioscience of Microbiota, Food and Health, 2025, 44 (3), 227—234. JCR: IF24:2.9(Q3Q3) AIS24:0.701(Q3Q3) WOS:001526478600004 EID:2-s2.0-105009783825 PMID:40636157 DOI:10.12938/bmfh.2024-110 OBD:673524»
Nawrot, D.; Koutníková, B.; Janďourek, O.; Konečná, K.; Novák, M.; Paterová, P.; Bárta, P.; Bouz, G.; Zitko, J.*; Doležal, M.: Antimicrobial and Antiproliferative Properties of 2-Phenyl-N-(Pyridin-2-yl)acetamides. Chemical Biology and Drug Design, 2025, 105 (1), art.e70030. JCR: IF24:3.3(Q2Q3) AIS24:0.514(Q3Q3) WOS:001400639000001 EID:2-s2.0-85215665614 PMID:39835639 DOI:10.1111/cbdd.70030 OBD:667321»
Niederquell, A.; Hofer, A.; Vraníková, B.; Kuentz, M.*: Approaching drug release performance from mesoporous silica formulations by modeling of chemical potentials. European Journal of Pharmaceutical Sciences, 2025, 214 (November), art.107283. JCR: IF24:4.7(Q1) AIS24:0.719(Q2) WOS:001589779400001 EID:2-s2.0-105017554366 PMID:40976377 DOI:10.1016/j.ejps.2025.107283 OBD:672681»
Niederquell, A.; Vraníková, B.; Kuentz, M.*: Ranking of apparent drug affinity to mesoporous silica utilizing a chromatographic screening method and a tree-based prediction model. International Journal of Pharmaceutics, 2025, 682 (September), art.125918. JCR: IF24:5.2(Q1) AIS24:0.764(Q2) WOS:001528048700002 EID:2-s2.0-105009822184 PMID:40609712 DOI:10.1016/j.ijpharm.2025.125918 OBD:672680»
Nuutinen, M.; Leskelä, R.; Fialová, D.; Haavisto, I.; Finne-Soveri, H.; Häsä, J.; Edgren, J.; van Hout, H.; da Cunha Leme, DE.; Hirdes, JP.; Onder, G.; Liperoti, R.*: Effect of discontinuing antipsychotic medications on the risk of hospitalization in long-term care: a machine learning-based analysis. BMC Medicine, 2025, 23 (1), art.484. JCR: IF24:8.3(Q1) AIS24:3.148(Q1) WOS:001553790500005 EID:2-s2.0-105013564261 PMID:40830460 DOI:10.1186/s12916-025-04304-7 OBD:673360»
Okuyan, B.*; Henman, MC.; Paudyal, V.; Weidmann, AE.; Cadogan, C.; Hazen, A.; Fialová, D.; Wirth, F.; Lutters, M.; Pouls, B.; Nazar, Z.; Al Raisi, F.; Stewart, D.: Research priorities of the European Society of Clinical Pharmacy (ESCP): a questionnaire-based study. International Journal of Clinical Pharmacy, 2025, 47 (6), 1770—1783. JCR: IF24:3.2(Q2) AIS24:0.623(Q2) WOS:001512267300001 EID:2-s2.0-105008465901 PMID:40540123 DOI:10.1007/s11096-025-01954-8 OBD:673355»
Oshikiri, H.; Taguchi, K.; Hirose, W.; Taniyama, Y.; Kamei, T.; Siegel, D.; Ross, D.; Kitson, RRA.*; Baird, L.*; Yamamoto, M.*: Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma. Molecular and Cellular Biology, 2025, 45 (2), 79—97. JCR: IF24:2.7(Q3Q3) AIS24:1.328(Q2Q2) WOS:001382430300001 EID:2-s2.0-85212957590 PMID:39717011 DOI:10.1080/10985549.2024.2438817 OBD:659482»
Paclíková, M.; Konečný, L.; Carazo, A.; Matoušová, K.; Kujovská Krčmová, L.; Blaha, V.; Šmahelová, A.; Mladěnka, P.*: Acetylsalicylic acid and vorapaxar are less active, while 4-methylcatechol is more active, in type 1 diabetic patients compared to healthy controls. Cardiovascular Diabetology, 2025, 24 (1), art.323. JCR: IF24:10.6(Q1Q1) AIS24:2.364(Q1Q1) WOS:001545589200001 EID:2-s2.0-105012859167 PMID:40775339 DOI:10.1186/s12933-025-02891-6 OBD:668126»
Panek, D.*; Pasieka, A.; Jończyk, J.; Gawlińska, M.; Zaręba, P.; Siwek, A.; Wolak, M.; Mordyl, B.; Głuch-Lutwin, M.; Latacz, G.; Brazzolotto, X.; Chantegreil, F.; Nachon, F.; Žďárová Karasová, J.; Pejchal, J.; Mžik, M.; Šesták, V.; Prchal, L.; Odvárková, J.; Soukup, O.; Korábečný, J.; Šorf, A.; Hamšíková, M.; Zemanová, L.; Múčková, Ľ.; Váňová, N.; Dryja, P.; Sałat, K.; Höfner, G.; Wanner, K.; Więckowska, A.; Malawska, B.: Multifunctional, Fluorene-Based Modulator of Cholinergic and GABAergic Neurotransmission as a Novel Drug Candidate for Palliative Treatment of Alzheimer's Disease. Angewandte Chemie - International Edition, 2025, 64 (6), art.e202420510. JCR: IF24:17.0(Q1) AIS24:3.524(Q1) WOS:001362189000001 EID:2-s2.0-85216938484 PMID:39523866 DOI:10.1002/anie.202420510 OBD:666475»
Pfeiffer, A.; Di Leo, L.; Baker Bechmann, M.; Nawabi, M.; Ambjörner, S.; Ardeshir-Larijani, D.; Thybo Colstrup, L.; Vedel Borchert, S.; Saaby, L.; Brodin, B.; Gajhede, M.; Loft Lund, X.; Čečková, M.; Brünner, N.; Stenvang, J.*: Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer. International Journal of Molecular Sciences, 2025, 26 (8), art.3790. JCR: IF24:4.9(Q1Q2) AIS24:1.122(Q2Q1) WOS:001475284600001 EID:2-s2.0-105003736168 PMID:40332396 DOI:10.3390/ijms26083790 OBD:674195»
Pflégr, V.; Konečná, K.; Stolaříková, J.; Österreicher, J.; Janďourek, O.; Krátký, M.*: Enhancing the Antimycobacterial Efficacy of Pyridine-4-Carbohydrazide: Linkage to Additional Antimicrobial Agents via Oxocarboxylic Acids. RSC Medicinal Chemistry, 2025, 16 (2), 767—778. JCR: IF24:3.6(Q2Q2) AIS24:0.863(Q2Q2) WOS:001347638300001 EID:2-s2.0-85208781072 PMID:39568598 DOI:10.1039/D4MD00663A OBD:653904»
Pflégr, V.; Stolaříková, J.; Karabanovich, G.; Maixnerová, J.; Pál, A.; Korduláková, J.; Šanderová, Z.; Liegertová, M.; Roh, J.; Trejtnar, F.; Vinšová, J.; Krátký, M.*: 5-(3,5-Dinitrophenyl)-1,3,4-oxadiazol-2-amine derivatives, their precursors, and analogues: Synthesis and evaluation of novel highly potent antitubercular agent. PLoS One, 2025, 20 (5), art.e0324608. JCR: IF24:2.6(Q2) AIS24:0.831(Q2) WOS:001499341800040 EID:2-s2.0-105006635619 PMID:40440331 DOI:10.1371/journal.pone.0324608 OBD:666093»
Pilařová, V.; Burianová, K.; Kosturko, Š.; Kulkarni, M.; Van Staden, J.; Nováková, L.*: Supercritical fluids in extraction, purification, and separation of selected Amaryllidaceae alkaloids. Separation and Purification Technology, 2025, 377 (December), art.133968. JCR: IF24:9.0(Q1) AIS24:1.069(Q1) WOS:001533495800013 EID:2-s2.0-105010566363 DOI:10.1016/j.seppur.2025.133968 OBD:673308»
Pilařová, V.; Plachká, K.; Gazárková, T.; Švec, F.; Garrigues, J.; Nováková, L.*: AI-powered insights into the UniSpray ionization in supercritical fluid chromatography-mass spectrometry. Journal of Chromatography A, 2025, 1756 (August), art.466064. JCR: IF24:4.0(Q1Q2) AIS24:0.473(Q3Q2) WOS:001504611800004 EID:2-s2.0-105006676501 PMID:40446414 DOI:10.1016/j.chroma.2025.466064 OBD:673329»
Pilařová, V.; Plachká, K.; Gazárková, T.; Švec, F.; Garrigues, J.; Nováková, L.*: Using artificial neural networks to elucidate retention interactions on stationary phases with amine moieties dedicated to supercritical fluid chromatography. Separation and Purification Technology, 2025, 356 (April), art.129965. JCR: IF24:9.0(Q1) AIS24:1.069(Q1) WOS:001334108300001 EID:2-s2.0-85205769050 DOI:10.1016/j.seppur.2024.129965 OBD:655328»
Plachká, K.; Pilařová, V.; Gazárková, T.; Garrigues, J.; Švec, F.; Nováková, L.*: Artificial Neural Networks: An Innovative Approach Used for Elucidation of Ionization Processes in Supercritical Fluid Chromatography-Mass Spectrometry. Analytical Chemistry, 2025, 97 (19), 10252—10263. JCR: IF24:6.7(Q1) AIS24:1.132(Q1) WOS:001485356300001 EID:2-s2.0-105004759873 PMID:40347148 DOI:10.1021/acs.analchem.5c00152 OBD:673312»
Plachká, K.; Pilařová, V.; Gazárková, T.; Švec, F.; Garrigues, J.; Nováková, L.*: AI-Enhanced Understanding of Retention Interactions in Supercritical Fluid Chromatography: Neural Network Insights into Retention on Selected Non-Polar Stationary Phases. Analytical Chemistry, 2025, 97 (4), 2164—2175. JCR: IF24:6.7(Q1) AIS24:1.132(Q1) WOS:001401440000001 EID:2-s2.0-85215836572 PMID:39835727 DOI:10.1021/acs.analchem.4c05176 OBD:673330»
Portillo, R.; Synova, T.; Štaud, F.*: Effects of prenatal cannabinoid use on the monoamine system in the fetoplacental unit: A systematic review of animal and human studies. Drug and Alcohol Dependence, 2025, 268 (March), art.112579. JCR: IF24:3.6(Q1Q1) AIS24:1.535(Q1Q1) WOS:001443322900001 EID:2-s2.0-85216524747 PMID:39899918 DOI:10.1016/j.drugalcdep.2025.112579 OBD:666510»
Pourová, J.*; Dias, P.; Pour, M.; Mladěnka, P.: The machinery of healthy vasoconstriction: an overview. Pflugers Archiv - European Journal of Physiology, 2025, 477 (9), 1163—1189. JCR: IF24:2.9(Q2) AIS24:1.092(Q1) WOS:001527763700001 EID:2-s2.0-105010508604 PMID:40640430 DOI:10.1007/s00424-025-03103-6 OBD:672773»
Pourová, J.*; Dias, P.; Pour, M.; Mladěnka, P.: The machinery of healthy vasodilatation: an overview. Pflugers Archiv - European Journal of Physiology, 2025, 477 (9), 1135—1162. JCR: IF24:2.9(Q2) AIS24:1.092(Q1) WOS:001502621300001 EID:2-s2.0-105007343015 PMID:40473983 DOI:10.1007/s00424-025-03096-2 OBD:672774»
Rataj, J.; Górecki, L.; Muthná, D.; Šorf, A.; Kryštof, V.; Klener, P.; Čečková, M.*; Řezáčová, M.*; Korábečný, J.*: Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges. Biomedicine & Pharmacotherapy, 2025, 182 (January), art.117788. JCR: IF24:7.5(Q1Q1) AIS24:1.328(Q1Q1) WOS:[On Hold] EID:2-s2.0-85213267299 PMID:39733588 DOI:10.1016/j.biopha.2024.117788 OBD:660593»
Reguli, A.; Bavlovič Piskáčková, H.; Lenčová-Popelová, O.; Kollárová Brázdová, P.; Štěrba, M.; Pedersen-Bjergaard, S.; Štěrbová-Kovaříková, P.*: Volumetric absorptive microsampling meets electromembrane extraction for the first time: Case example of doxorubicin and its metabolite in whole blood samples. Analytica Chimica Acta, 2025, 1335 (January), art.343459. JCR: IF24:6.0(Q1) AIS24:0.837(Q1) WOS:001368188400001 EID:2-s2.0-85209753594 PMID:39643313 DOI:10.1016/j.aca.2024.343459 OBD:667453»
Rojas-Vargas, JA.*; García-Díaz, J.; Escalona-Arranz, JC.; Chlebek, J.; Monzote, L.; Setzer, WN.; Castillo-Garit, JA.*: Protozoan Neglected Tropical Diseases (NTDs) Target Inhibition of Alkaloids from Croton linearis Jacq Leaves: A Molecular Docking and ADMET Approach. Pharmaceuticals, 2025, 18 (11), art.1715. JCR: IF24:4.8(Q1Q1) AIS24:0.873(Q2Q2) WOS:001623771100001 EID:2-s2.0-105022866236 PMID:41304960 DOI:10.3390/ph18111715 OBD:673589»
Saarinen, S.; Khan, R.; Patrian, M.; Fuenzalida-Werner, JP.; Costa, RD.; Zimčík, P.; Nováková, V.; Ruoko, T.; Tkachenko, NV.; Anaya-Plaza, E.*; Kostiainen, MA.*: Elucidating the Supramolecular Interaction of Positively Supercharged Fluorescent Protein with Anionic Phthalocyanines. Advanced Biology, 2025, 9 (5), art.2400308. JCR: IF24:2.6(Q3) AIS24:0.869(Q2) WOS:001331770800001 EID:2-s2.0-85206354606 PMID:39410834 DOI:10.1002/adbi.202400308 OBD:673303»
Salam, R.; Bakker, M.; Krutáková, M.; Štefela, A.; Pávek, P.; Duintjer Tebbens, J.; Zitko, J.*: The discovery of a new nonbile acid modulator of Takeda G protein-coupled receptor 5: An integrated computational approach. Archiv der Pharmazie, 2025, 358 (1), art.e2400423. JCR: IF24:3.6(Q2Q2Q2) AIS24:0.527(Q3Q2Q3) WOS:001395148400001 EID:2-s2.0-85214661840 PMID:39801251 DOI:10.1002/ardp.202400423 OBD:673204»
Siatka, T.; Máťuš, M.; Moravcová, M.; Harčárová, P.; Lomozová, Z.; Matoušová, K.; Suwanvecho, Ch.; Kujovská Krčmová, L.; Mladěnka, P.*: Biological, dietetic and pharmacological properties of vitamin B9. Npj Science of Food, 2025, 9 (1), art.30. JCR: IF24:7.8(Q1) AIS24:1.167(Q1) WOS:001443281700001 EID:2-s2.0-105000411819 PMID:40075081 DOI:10.1038/s41538-025-00396-w OBD:667442»
Suwanvecho, Ch.; Kujovská Krčmová, L.*; Švec, F.: Volumetric dried blood spot microsampling: A sustainable, patient-friendly, and practical approach for retinol and alpha-tocopherol analysis in a clinical setting. Methods, 2025, 243 (November), 40—48. JCR: IF24:4.3(Q1Q2) AIS24:1.193(Q1Q2) WOS:001561944800001 EID:2-s2.0-105014031175 PMID:40850402 DOI:10.1016/j.ymeth.2025.08.006 OBD:672610»
Suwanvecho, Ch.; Vyleťalová, L.; Přívratská, N.; Laolertworakul, P.; Turoňová, D.; Vošmik, M.; Kujovská Krčmová, L.*; Švec, F.: Dried urine spot as a stable, green, and practical microsampling tool in clinical practice for quantification of neopterin and creatinine. Green Chemistry, 2025, 27 (36), 11007—11020. JCR: IF24:9.2(Q1Q1) AIS24:1.631(Q1Q1) WOS:001522484900001 EID:2-s2.0-105009945451 DOI:10.1039/d5gc00956a OBD:667176»
Svobodová, G.; Horní, M.; Velecká, E.; Boušová, I.*: Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review. Archives of Toxicology, 2025, 99 (January), 1—22. JCR: IF24:6.9(Q1) AIS24:1.301(Q1) WOS:001339255400001 EID:2-s2.0-85207177848 PMID:39443317 DOI:10.1007/s00204-024-03889-x OBD:654213»
Svobodová, Z.*; Křížová, L.; Matějková, N.; Smělá, D.; Beránek, M.; Bílková, Z.; Horstkotte, B.: Lab-in-Syringe Automated Miniaturized Bioconjugation of Magnetic Beads with Anti-SARS-CoV2 Antibodies. ACS Omega, 2025, 10 (29), 31359—31367. JCR: IF24:4.3(Q2) AIS24:0.674(Q2) WOS:001532253200001 EID:2-s2.0-105013299369 PMID:40757293 DOI:10.1021/acsomega.4c11126 OBD:667586»
Šafratová, M.; Chen, Y.; Hošťálková, A.; Chlebek, J.; Hsieh, Ch.; Chen, B.; Cahlíková, L.; Kosturko, Š.; Backlund, A.; Horng, J.; Hwang, T.*; Kořínek, M.*: Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure-Activity Relationship. Influenza and Other Respiratory Viruses, 2025, 19 (10), art.e70166. JCR: IF24:4.2(Q1Q1) AIS24:1.479(Q1Q1) WOS:001588522500001 EID:2-s2.0-105017832667 PMID:41047521 DOI:10.1111/irv.70166 OBD:673277»
Šafratová, M.; Vrabec, R.; Blunden, G.; Cahlíková, L.; Křoustková, J.*: Specialized metabolites of the genus Zephyranthes Herb.: a critical review on taxonomy and phytochemistry. Phytochemistry Reviews, 2025, 24 (3), 2235—2270. JCR: IF24:7.6(Q1) AIS24:1.387(Q1) WOS:001255292900001 EID:2-s2.0-85197233003 DOI:10.1007/s11101-024-09931-1 OBD:655650»
Špulák, M.; Nelic, D.; Randáková, A.; Konečná, K.; Janďourek, O.; Smutná, L.; Kubíček, V.; Gathergood, N.; Pourová, J.; Pávek, P.; Pour, M.; Svoboda, D.; Ďurinová, A.; Jakubík, J.; Trejtnar, F.*: Evaluation of pharmacokinetics, pharmacodynamics, and toxicity of potential quinazoline bronchodilators derived from vasicinone. Journal of Pharmacology and Experimental Therapeutics, 2025, 392 (8), art.103636. JCR: IF24:3.8(Q2) AIS24:0.999(Q1) WOS:001541487500001 EID:2-s2.0-105010082617 PMID:40651111 DOI:10.1016/j.jpet.2025.103636 OBD:672423»
Štefela, A.; Dohnalová, K.; Laštůvková, H.; Škoda, J.; Bajnoková, M.; Lestavel, S.; Touche, V.; Kašpar, M.; Kudová, E.; Hroch, M.; Mičuda, S.; Kučera, O.; Pávek, P.*: The farnesoid X receptor (FXR) antagonist 7beta-isopropylchenodeoxycholic acid improves glucose metabolism in mice on a Western diet. Pharmacological Research, 2025, 221 (November), art.107950. JCR: IF24:10.5(Q1) AIS24:2.019(Q1) WOS:001576953700002 EID:2-s2.0-105016234769 PMID:40945669 DOI:10.1016/j.phrs.2025.107950 OBD:672225»
Štěrbová, K.; Nguyen, LT.; Žofka, M.; Matoušková, P.; Krátký, J.; Skálová, L.*: Environment-like exposure of free-living stages of Haemonchus contortus to albendazole: The intra- and intergeneration stability of altered expression of UDP-glycosyl transferases and ABC-transporters. Chemosphere, 2025, 376 (May), art.144281. EID:2-s2.0-85219659521 PMID:40056817 DOI:10.1016/j.chemosphere.2025.144281 OBD:673065»
Tesař, O.; Doseděl, M.; Kuběna, AA.; Malá-Ládová, K.; Prokešová, R.; Brabcová, I.; Hajduchová, H.; Červený, M.; Chloubová, I.; Vlček, J.; Tóthová, V.; Malý, J.*: Errors Associated With Medication Administration by a Nurse During Hospitalisation: A Prospective Observational Multicentric Study. Nursing Open, 2025, 12 (1), art.e70139. JCR: IF24:2.3(Q1) AIS24:0.650(Q2) WOS:001393809300001 EID:2-s2.0-85214980526 PMID:39793977 DOI:10.1002/nop2.70139 OBD:673547»
Timbilla, AA.; Vrabec, R.; Havelek, R.; Řezáčová, M.; Chlebek, J.; Blunden, G.; Cahlíková, L.*: The anticancer properties of harmine and its derivatives. Phytochemistry Reviews, 2025, 24 (2), 1535—1564. JCR: IF24:7.6(Q1) AIS24:1.387(Q1) WOS:001314852800002 EID:2-s2.0-85204352606 DOI:10.1007/s11101-024-09978-0 OBD:653665»
Tranová, T.; Matzick, K.; Loskot, J.*; Macháčková, J.; Nevyhoštěná, M.; Macho, O.; Trnčáková, V.; Komersová, A.; Mužíková, J.: Combining Selective Laser Sintering and Fused Deposition Modeling of Pharmaceutical Polymers: A Novel Approach to Prepare Intestine-Targeted Tablets. Macromolecular Materials and Engineering, 2025, 310 (6), art.2400460. JCR: IF24:4.6(Q2Q2) AIS24:0.639(Q2Q2) WOS:001426031600001 EID:2-s2.0-85219699128 DOI:10.1002/mame.202400460 OBD:672747»
Trejtnar, F.*; Bárta, P.; Kozempel, J.; Vlk, M.; Ďurinová, A.; Kuchařová, M.; Pávek, P.: Terbium-161 in nuclear medicine: Preclinical and clinical progress in comparison with lutetium-177. Nuclear Medicine and Biology, 2025, 144—145 (May-June), art.108998. JCR: IF24:3.0(Q2) AIS24:0.698(Q2) WOS:001429337000001 EID:2-s2.0-85217897336 PMID:39978166 DOI:10.1016/j.nucmedbio.2025.108998 OBD:672311»
Urbánková Rathouská, J.; Mrázková, J.; Andrýs, C.; Jankovičová, K.; Tripská, K.; Fikrová, P.; Němečková, I.; Eissazadeh, S.; Wohlfahrt, P.; Piťha, J.; Nachtigal, P.*: Soluble endoglin reflects endothelial dysfunction in myocardial infarction patients: a retrospective observational study. International Journal of Medical Sciences, 2025, 22 (13), 3220—3228. JCR: IF24:3.2(Q1) AIS24:0.697(Q2) WOS:001525510500002 EID:2-s2.0-105010759708 PMID:40765559 DOI:10.7150/ijms.115222 OBD:667619»
Vávrová, P.; Janďourek, O.; Diepoltová, A.; Nachtigal, P.; Konečná, K.*: The appropriate nutrient conditions for methicillin-resistant Staphylococcus aureus and Candida albicans dual-species biofilm formation in vitro. Scientific Reports, 2025, 15 (1), art.183. JCR: IF24:3.9(Q1) AIS24:1.031(Q1) WOS:001389989100006 EID:2-s2.0-85213978834 PMID:39747199 DOI:10.1038/s41598-024-83745-1 OBD:673430»
Věříš, A.*; Loskot, J.; Andrýs, R.; Konečná, K.; Janďourek, O.; Šnejdrová, E.: Chitosan-based film-forming systems with cannabidiol: a novel topical strategy for antimicrobial therapy. International Journal of Pharmaceutics, 2025, 682 (September), art.125940. JCR: IF24:5.2(Q1) AIS24:0.764(Q2) WOS:001548328400003 EID:2-s2.0-105010900966 PMID:40659166 DOI:10.1016/j.ijpharm.2025.125940 OBD:667349»
Vosála, O.; Krátký, J.; Matoušková, P.; Rychlá, N.; Štěrbová, K.; Raisová Stuchlíková, L.; Vokřál, I.; Skálová, L.*: Biotransformation of anthelmintics in nematodes in relation to drug resistance. International Journal for Parasitology: Drugs and Drug Resistance, 2025, 27 (April), art.100579. JCR: IF24:3.4(Q1Q2) AIS24:0.894(Q1Q2) WOS:001403640100001 EID:2-s2.0-85215129184 PMID:39827513 DOI:10.1016/j.ijpddr.2025.100579 OBD:673064»
Vrabec, R.; Drašar, P.; Opletal, L.; Kosturko, Š.; Blunden, G.; Cahlíková, L.*: Alkaloids from the genus Vinca L. (Apocynaceae): a comprehensive biological and structural review. Phytochemistry Reviews, 2025, 24 (5), 3665—3735. JCR: IF24:7.6(Q1) AIS24:1.387(Q1) WOS:001456111700001 EID:2-s2.0-105001793945 DOI:10.1007/s11101-025-10102-z OBD:664865»